Maternal aa/epa ratio and triglycerides as potential biomarkers of patients at major risk for pharmacological therapy in gestational diabetes

HIGHLIGHTS

  • who: Chiara Maria Soldavini and colleagues from the Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy have published the research work: Maternal AA/EPA Ratio and Triglycerides as Potential Biomarkers of Patients at Major Risk for Pharmacological Therapy in Gestational Diabetes, in the Journal: Nutrients 2022, 2502 of 12/05/2022
  • what: The aim of the present randomized double-blind trial was to evaluate the metabolic effects on GD patients of anti-inflammatory, antioxidant nutraceutical supplementation with omega-3 fatty_acids, anthocyanins, and alpha-cyclodextrins associated with appropriate nutritional coaching versus nutritional coaching . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?